J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 17-Jul-2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-May-2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Feb-2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding allotment of 259077 securities pursuant to ESOP/ESPS at its meeting held on July 22, 2025

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Final Dividend 2024-25 is 30-Jul-2025.

NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of Detailed public statement in terms of Regulations 3(1) and 4 Read with Regulations 13(4), 14 (3) and 15(2) and other applicable regulations of the securities and Exchange Board of India (SAST) Regulations, 2011 , as amended, to the eligible shareholders  ( as defined below) of the company.

NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of Public announcement under Regulation 3(1) and 4 Read with Regulations 13(1), 14 and 15(1) of the securities and exchange Board of India ( SAST) Regulations, 2011 as amended.

NovaaOne Capital Private Limited has submitted to the Exchange a copy of Public Announcement - Open Offer for J.B. Chemicals & Pharmaceuticals Ltd. (the Target Company ) under Regulation 3 (1) and 4 read with Regulations 13(1), 14 and 15 (1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as amended

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 08-Feb-2025.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Final Dividend is 14-Aug-2024.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Feb-2024.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Split/Subdivision is 18-Sep-2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Aug-2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors at its meeting held on May 24, 2023, has considered and approved subdivision of 77377584 equity shares of 2 each into 154755168 equity shares of 1 each.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Feb-2023.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Aug-2022.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 24-Feb-2022.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 02-Sep-2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Feb-2021.

JICICI Securities Limited has submitted to the Exchange a copy of Pre Offer Advertisement in Accordance with Regulations 18(7) of the Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeovers) Regulations 2011 as Amended and Corrigendum to the Detailed Public Statement for the Attention of the Public Shareholders of J B Chemicals and Pharmaceuticals Limited.

JB Chemicals & Pharmaceuticals Limited had intimated the 17-Sep-2020 as the record date. The Company has now informed the Exchange that the Record date has been revised to 23-Sep-2020 for the purpose of Dividend.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a copy of advertisement published on September 5, 2020 in furtherance to their Letter of Offer dated September 4, 2020

ICICI Securities Limited has submitted to the Exchange a copy of Letter of Offer JB Chemicals & Pharmaceuticals Limited Target Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of final Dividend 2019-20 is 17-Sep-2020.

��ICICI Securities Limited has submitted to the Exchange a copy of detailed Public Statement in terms of Regulation 3(1), Regulation 4 read with Regulation 13(4), Regulation 14(3), Regulation 15(2) and Regulation 15(3) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd (Target Company).

ICICI Securities Limited has submitted to the Exchange a copy of Public announcement dated July 02, 2020 for the Open offer of��J.B. Chemicals & Pharmaceuticals Limited( Target Company).

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as March 4, 2020 for the purpose of Interim Dividend

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Post Buyback Public Announcement.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Filing of Letter of Offer pursuant to provisions of the SEBI (Buy-back of Securities) Regulations, 2018.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Public Announcement - Buyback of Shares.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company has, at its meeting held on November 12, 2019 inter-alia approved Buy-back of up to 29,54,545 fully paid-up Equity Shares of face value of Rs. 2/- each by the Company (representing 3.68% of the total paid-up equity shares of the Company) at a price of Rs. 440/- (Rupees four hundred forty Only) per Equity Share payable in cash for a total consideration not exceeding Rs.130 crores/- (Rupees one hundred thirty Crores only) (excluding transaction costs) which is 9.33% and 9.38% of the total

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as November 22, 2019 for the purpose of Buy-back.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as August 16, 2019 to ascertain eligibility of the beneficial owners/shareholders of the Company's shares to receive the dividend for FY 2018-19, if declared at the annual general meeting.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a Copy of Post Buyback Public Advertisement for Buy back of Equity Shares of J.B. Chemicals & Pharmaceuticals Limited pursuant to the provisions of Regulation 19(7) of SEBI (Buy Back of Securities) Regulations, 1998.

Vivro Financial Services Private Limited has submitted to the Exchange a Copy Certified True Copy of the Resolution Passed By the Board of Directors at its meeting held on August 31, 2018 along with Public Announcement For The Attention Of Equity Shareholders/ Beneficial Owners Of Equity Shares Of the Company For Buy-Back Of Equity Shares Through The Tender Offer Route As Prescribed Under The Securities And Exchange Board Of India (Buy- Back Of Securities) Regulations, 1998, As Amended.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a Copy of Public Announcement For The Attention Of Equity Shareholders/ Beneficial Owners Of Equity Shares Of the Company For Buy-Back Of Equity Shares Through The Tender Offer Route As Prescribed Under The Securities And Exchange Board Of India (Buy- Back Of Securities) Regulations, 1998, As Amended.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as September 12, 2018 To determine the entitlement and names of Equity Shareholders, who shall be entitled to participate in the proposed offer for Buy-back of up to 33,33,333 Equity Shares of the Company at the price of Rs.390/- per Equity Share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding�� Copy of Board Resolution approving Buy-Back.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Intimation of Record Date under Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company has, at its meeting held on August 31, 2018 approved the Buy-back of up to 33,33,333 fully paid up Equity Shares of face value of Rs. 2/- each by the Company (representing 3.99% of the total paid up Equity Share capital of the Company) at a price of Rs 390/- (Rupees Three Hundred and Ninety only) per Equity Share payable in cash for a total consideration not exceeding Rs.130/- crores (Rupees One Hundred and Thirty crores only) (excluding transaction costs such as fees, brokerage, taxes,

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from August 29, 2018 to September 4, 2018 (both days inclusive) for the purpose of To ascertain eligibility of the beneficial owners/ shareholders for dividend for FY 2017-18, if declared at the annual general meeting.

The company had informed the Exchange that the Register of Members and Share Transfer Books will remain closed from September 13, 2017 to September 19, 2017 (both days inclusive) To ascertain eligibility of the beneficial owners/ shareholders for dividend for FY 2016-17, if declared at the Annual General Meeting. The company has now inform the exchange that the Register of Members and Share Transfer Books will remain closed from September 13, 2017 to September 19, 2017 (both days inclusive) for the purpose of AGM and Dividend.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from September 13, 2017 to September 19, 2017 (both days inclusive) To ascertain eligibility of the beneficial owners/ shareholders for dividend for FY 2016-17, if declared at the Annual General Meeting

JB Chemicals & Pharmaceuticals Limited has informed the Exchange a copy of post Buy-Back Announcement for the attention of equity shareholders / beneficial owners of equity shares of J.B. Chemicals & Pharmaceuticals Limited

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Public Announcement Buy-back of Equity Shares of the Company .

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Filing of copy of Board Resolution pursuant to the provisions of SEBI (Buy-Back of Securities) Regulation, 1998 ( said Regulations ).

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as June 2, 2017 for the purpose of to determine the entitlement and names of Equity Shareholders, who shall be entitled to participate in the proposed offer for Buy-back of up to 12,50,000 Equity Shares of the Company at the price of Rs.400/- per Equity Share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company has, at its meeting held on May 23, 2017 approved the Buy-back of up to 12,50,000 fully paid up Equity Shares of face value of Rs. 2/- each by the Company (representing 1.47% of the total paid up Equity Share capital of the Company) at a price of Rs.400/- (Rupees four hundred) per Equity Share payable in cash for a total consideration not exceeding Rs. 50/- crores (Rupees fifty crores only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc), which is not exceeding

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from August 16, 2016 to August 23, 2016 (both days inclusive) for the purpose to ascertain eligibility of the beneficial owners / shareholders for final dividend for FY 2015-16, if declared at the annual general meeting.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as March 19, 2016 for the purpose of payment of Interim dividend for FY 2015-16.